Literature DB >> 1711011

The contribution of beta-strand residues to serologic epitopes on the A beta k polypeptide.

B N Beck1, A E Nilson, M P Bell, C G Chase, D J McKean.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1711011     DOI： 10.1007/bf00216703

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  16 in total

1.  Alteration of a non-polymorphic residue in a class II E beta gene eliminates an antibody-defined epitope without affecting T cell recognition.

Authors:  I J Griffith; F M Carland; L H Glimcher
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

2.  Functional sites on Ia molecules: a molecular dissection of A alpha immunogenicity.

Authors:  D Landais; C Waltzinger; B N Beck; A Staub; D J McKean; C Benoist; D Mathis
Journal:  Cell       Date:  1986-10-24       Impact factor: 41.582

Review 3.  Mutations of class II MHC molecules.

Authors:  L H Glimcher; I J Griffith
Journal:  Immunol Today       Date:  1987

4.  Increased specificity of PCR-amplified products by size-fractionation of restriction enzyme-digested template genomic DNA.

Authors:  B N Beck; S N Ho
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

5.  T-cell recognition of Ia molecules selectively altered by a single amino acid substitution.

Authors:  M A Brown; L A Glimcher; E A Nielsen; W E Paul; R N Germain
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

6.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

7.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules.

Authors:  L H Glimcher; S O Sharrow; W E Paul
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  DNA sequence analysis of I-Ak beta mutants reveals serologically immunodominant region.

Authors:  B N Beck; L R Pease; M P Bell; J M Buerstedde; A E Nilson; G G Schlauder; D J McKean
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.